A novel NOX1 and NOX4 inhibitor, an EMA reflection paper on drug development, and the genetics of NAFLD
Posted 27th March 2019 by Joshua Sewell
Following the 2nd Global NASH Congress, we have made the following presentation slides from Alexandre Grassin, Elmer Schabel & Luca Valenti available.
8 Free Tools for Genetic Engineers, Molecular and Synthetic Biologists
Posted 12th October 2018 by Jane Williams
Having a powerful set of tools is essential in life science research so we’ve compiled the best free platforms for genetic engineers, molecular and synthetic biologists.
Biologics Congress Europe – Slide release
Posted 6th June 2018 by Jane Williams
Presented at the 4th Biologics & Biosimilars Congress, these free slides are now available to download and share with your colleagues.
The Global NASH Congress – Slide release
Posted 23rd May 2018 by Jane Williams
An increasing number of people are being diagnosed with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year, and the primary method of treatment is weight loss. With no approved medicines on the market, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood, and definitive diagnostic methods are invasive, so development has been slow.
Over the course of the Global NASH Congress, 40 expert-led presentations and interactive roundtable discussions explored these key issues. If you were unable to attend, please enjoy these free slides from Eric Hughes, Jon Reik and Pierre Bedossa.
The Big List of Synthetic Biology Companies and Investors
Posted 11th August 2017 by Jane Williams
2013 saw a dramatic increase in synthetic biology investment: a trend which continues year-on-year. In 2016 there were 8x more investments than in 2005 and having already surpassed 2016’s numbers, 2017 is set to be the biggest yet.
The Big List of Microbiome Companies and Investors
Posted 14th July 2017 by Jane Williams
A critical point in any field of research is that of commercialisation; when research builds to the point that the dam bursts, bottlenecks open and opportunities are ripe. 2016 saw the largest peak in microbiome investment since 2012 when the CRISPR-Cas9 ‘instructions’ were published.
The Human Gut Microbiome Viewed Across Geography
Posted 18th January 2017 by Jane Williams
Chronic illnesses such as IBD, obesity and diabetes were once considered ‘western’ diseases. However, changes to diet and lifestyle are steadily taking their toll and prevalence rates are rising across the globe. (1)
The Top 10 Plant Genome Databases
Posted 10th October 2016 by Jane Williams
Finding the information that you need on plant genomes is difficult when published data is spread across a vast amount of journals and the rest is unpublished. So we gathered together 10 of the best plant genome databases to make your job easier.
